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ACUTE RESPIRATORY INFECTIONS IN CIVILIAN ADULTS
I I . Chnical and Serologic Observations in a Vaccine Study Group

F.

Cox,
C.

JR., M.D.,* E. A. T I M M , * *

I . W. M C L E A N , * * *

F. WEISS,**** AND E . L . Q U I N N , M.D.*

I N RECENT YEARS numerous reports have been published concerning the efficacy of
killed influenza and adenovirus vaccines in the prevention or modification of iOness
due to these viral agents. It has been established that such vaccines conferred a significant degree of protection during epidemic outbreaks of acute respiratory infection
due to the various types of influenza in civilian and military groups and against adenovirus outbreaks in military recruits.'"'' It has also been shown that multiple influenza
and adenoviruses may be combined in a single vaccine without loss of antigenic
efficiency of the individual antigens in the mixture.'
A study to determine the clinical efficacy of several polyvalent influenza, adenovirus and parainfluenza vaccines in a heterogeneous adult civilian population group
was begun in September, 1959 as part of a continuing respiratory infection investigation program. Four months after the institution of this study, an epidemic outbreak
of Asian influenza occured in the Detroit area. This chance happening presented an
opportunity to observe the protective rate of the various polyvalent vaccines in prevention of an epidemic illness due to one agent (Influenza A2) contained in certain
of the vaccines under study.
MATERIALS AND METHODS

Three hundred adult hospital employees volunteeded to participate in the study. Two
hundred and forty of the subjects had never received respiratory virus vaccines. They were
divided into four equal groups of 60 each by random selection. The remaining 60 subjects
received either influenza or adenovirus vaccine or a placebo in the previous two years, but
not more recently than 12 months before. These subjects were divided by random selection
into two groups of 30 each resulting in a total of six groups. The vaccine administered to
each group and the number of subjects completing the study is presented in Table I . The
vaccines were coded by the statistician and neither the subjects, clinical observers or laboratory investigators had knowledge of the composition of material given any subject until
all clinical and serologic data were completed. Commercially prepared vaccines and a
*Division of Infectious Diseases.
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Table I
Composition of Vaccines and Division of Subjects into Groups
Test Vaccines
Influenza
Influenza-Adenovirus
Influenza-Adenovirus-Parainfluenza
Placebo
Adenovirus
Parainfluenza
Total

No. of Subjects
57
60
58
59
28
29
291

placebo were employed. The influenza vaccine contained PR-8, A / A A '57, Great Lakes
and Asian strains combined in a final concentration of 100, 100, 100 and 200 CCA units
respectively per ml. of final vaccine. The pooled adenovirus vaccine contained Types 3, 4
and 7 strains and the Parainfluenza Types 1 and 3 strains. Each vaccine and the placebo
also contained 3.5 mg. of A L P O j per ml. and Merthiolate 1:10,000. Polyvalent influenza,
infltjenza-adenovirus, influenza-adenovirus-parainfluenza or placebo were administered to
subjects who had never received prior vaccination. Adenovirus or parainfluenza vaccine was
given to the previously vaccinated group.
One ml. of vaccine or placebo was administered to each subject subcutaneously in the
left deltoid at the outset of the study (Sept., 1959) and a second injection was given one
month later. Blood was obtained for serologic testing at 0, 4 and 8 weeks. I n March, 1960
at the termination of the Asian Influenza epidemic, all subjects were again bled and the sera
were paired with the previous specimens. Asian influenza hemagglutination inhibition titers'
of the coded sera were determined in the laboratory of Drs. McLean and Timm. A fourfold increase in titer between the 8th week (Oct., 1959) blood and 24th week (March, 1960)
blood specimens was considered to represnt serologic evidence of Asian influenza infection.
A l l participants were interviewed by a nurse assigned to the study once every two weeks
and were also instructed to report to the clinic at the time of onset of any acute respiratory
or febrile illness. A special study history form was completed by the nurse at each visit.
If the temperature was 100° F or more, the subject was examined by one of us (F. C. or
E. Q.) and a throat culture for Beta hemolytic streptococci obtained. Based on the history
examination and results of the throat culture, a clinical impression was formulated. Subjects
who were afebrile with localized acute respiratory symptoms were classified as having a
Common Cold. I n subjects with a temperature of 100° or above with systemic as well as
acute respiratory symptoms. Acute Respiratory Disease was diagnosed. Streptococcal sore
throat was not encountered during the study period under analysis. The clinical diagnosis
served as a rough estimate of the severity of the acute respiratory illness.
The clinical data were correlated later with the presence or absence of a four-fold
rise in Asian influenza titer by employment of computer analysis of the data.* The correlation of clinical illness and antibody titer changes to other antigens in test vaccines will be
the subject of a later report.
RESULTS

The 1960 epidemic outbreak of Asian influenza previously mentioned is depicted
in Figure 1. The top two graphs illustrate the number of cases of "pneumonia" and
"influenza" reported to the Detroit Department of Health**, before, during and after
this epidemic. The lower graph shows the biweekly rate of all respiratory illness that
occurred i n the entire study group between Nov., 1959 and D e c , 1960. A sharp
rise i n incidence of respiratory illness occurred early i n 1960, suggesting that our
•Accomplished by R. R. Gauch, Parke, Davis & Co., Ann Arbor, Michigan.
*Data on the incidence of influenza and pneumonia, and permission to use the data kindly supplied
by Drs. Joseph G, Molner and Charles P. Anderson, Detroit Department of Health.
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volunteer group had probably experienced the same epidemic outbreak that was
observed in the general population.
The incidence of occurrence of a four-fold rise in Asian influenza antibody titer
in the hospital study group is presented in Table I I . This and subsequent tables give
the rate per 100 subjects, or percentage. Those subjects who received placebo or
vaccine which did not contain Asian influenza antigen are tabulated in the nonprotected group, while those who received a vaccine containing Asian influenza
antigen are listed in the protected group. This table also depicts the incidence of serologic evidence of infection in the absence of a respiratory illness and the association
of both serologic and clinical evidence of an acute respiratory illness.
Table I I
Incidence of Four-Fold Rise in Asian Influenza Antibody
Titer between October, 1959 and March, 1960
Not Associated with
Respiratory Illness
Non-Protected Groups
Placebo
Adenovirus
Parainfluenza
Protected Groups
Influenza
Influenza-Adenovirus
Influenza-Adenovirus-Parainfluenza
Protection Rate

Associated with
Respiratory Illness

5%
7% Aver. 5%
3%

15%
28.5% Aver. 19.2%
14%

7%
0% Aver. 4%
5%

7%
5% Aver. 4%
0%
79.7% (P = .05)

These data indicate that serologic response without clinical evidence of infection
occurred with approximately equal frequency in both the non-protected and protected
groups. In contrast when both serologic and clinical evidence of acute respiratory
infection was observed, the incidence was 19.2 per cent in the unprotected group
and 4 per cent in the protected group, representing a protection rate of 79 per cent.
This difference is statistically significant. (P value = .05) Among the protected
groups it is of interest to note that clinical infection did not occur in the group that
received the combined influenza-adenovirus-parainfluenza vaccine while the rate for
the other two groups was 7 and 5 per cent. This difference is on the borderline of
statistical significance and cannot be explained on the basis of difference in preepidemic antibody titer since these titers were essentially similar in the three groups.
It is attractive to speculate that the addition of parainfluenza antigen to the vaccine
was responsible for the enhanced protection, but the number of subjects is too small
to permit this conclusion.
Since acute respiratory illness associated with a four-fold rise in Asian influenza
antibody titer occurred in both the non-protected and protected groups (although at
a lower rate in the latter) it was of interest to determine if vaccination exerted any
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Table I I I
Severity of Respiratory Illness Associated with a Four-Fold Rise in Asian Influenza
Antibody Titer as Determined by the Clinical Diagnoses and Duration of Illness
Non-Protected Group

Protected Group

1. Clinical Diagnosis:
Common Cold
ARD-Influenza
Pneumonia

33%
60%
4%

36%
64%
0%

2. Duration of Iflness:
1-3 days
4-7 days
8-17 days
-f- 14 days

28%
40%
20%
10%

22%
44%
33%
0%

influence on the severity of the illness when it did occur (Table I I I ) . The clinical
diagnosis and duration of common cold, acute respiratory disease and influenza was
made with approximately equal frequency in both groups. There was one instance
of pneumonia in a non-protected subject. Similarly, the duration of illness was essentially the same for the two groups. These data indicate that if a symptomatic respiratory illness associated with a diagnostic rise in antibody titer occurred, vaccination
did not modify the severity of the illness.

Table IV
Incidence of Respiratory Illnesses in Absence of Four-Fold Rise in
Influenza Antibody Titer between January 1, I960 and March 15, 1960
Non-Protected Groups
Placebo
Adenovirus
Parainfluenza

45%
28.5%
34%

Aver. 35.8%

Protected Groups
Influenza
Influenza-Adenovirus
Influenza-Adenovirus-Parainfluenza

26%
45%
40%

Aver. 37%

Table I V illustrates the incidence of acute respiratory illness not associated with
a rise in antibody titer to Asian influenza (and therefore presumably respiratory illness
other than Asian influenza). It is apparent that infection rates were approximately
equal for both the non-protected and protected groups.

SUMMARY

In the course of a study concerning the protective value of inactivated polyvalent respiratory vaccines an Asian Influenza epidemic occurred. Of six vaccines
employed in this study, three contained Asian influenza antigen. The incidence of
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INFLUENZA EPIDEMIC
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Figure 1
The occurrence of Pneumonia, Influenza and Respiratory Illnesses in Detroit and in the study group.

serologically proven influenza associated with clinical respiratory illness was 19.2
per cent in the subjects who did not receive vaccine containing the Asian influenza
antigen and 4 per cent in the group who did, a protection rate of 79 per cent. These
figures are comparable to those obtained by other investigators.'"* The severity and
course of respiratory illness occurring in subjects with four-fold rise in Asian influenza
antibody titer were the same in the protected and non-protected groups in this study.
Finally, the protection afforded by the vaccine was specific.
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